Haemophilia

Cover image for Vol. 17 Issue 3

May 2011

Volume 17, Issue 3

Pages 383–569

  1. Review Articles

    1. Top of page
    2. Review Articles
    3. Original Articles
    4. Letters to the Editors
    5. Abstracts
    1. You have free access to this content
      Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations (pages 383–392)

      C. HERMANS, P. DE MOERLOOSE, K. FISCHER, K. HOLSTEIN, R. KLAMROTH, T. LAMBERT, G. LAVIGNE-LISSALDE, R. PEREZ, M. RICHARDS, G. DOLAN and ON BEHALF OF THE EUROPEAN HAEMOPHILIA THERAPY STANDARDISATION BOARD

      Article first published online: 15 FEB 2011 | DOI: 10.1111/j.1365-2516.2010.02449.x

  2. Original Articles

    1. Top of page
    2. Review Articles
    3. Original Articles
    4. Letters to the Editors
    5. Abstracts
    1. Treatment

    2. Low risk of inhibitor formation in haemophilia A patients following en masse switch in treatment to a third generation full length plasma and albumin-free recombinant factor VIII product (ADVATE®) (pages 407–411)

      C. L. BACON, E. SINGLETON, B. BRADY, B. WHITE, B. NOLAN, R. M. GILMORE, C. RYAN, C. KEOHANE, P. VINCE JENKINS and J. S. O’DONNELL

      Article first published online: 8 MAR 2011 | DOI: 10.1111/j.1365-2516.2010.02430.x

    3. You have full text access to this OnlineOpen article
    4. Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery (pages 428–432)

      C. R. M. HAY, A. HELLMANN, A. DMOSZYNSKA, T. BAGLIN, D. O’SHAUNESSEY, M. MAKRIS, R. SHAIKH-ZAIDI and C. H. DASH

      Article first published online: 3 MAR 2011 | DOI: 10.1111/j.1365-2516.2010.02441.x

    5. Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials (pages 433–438)

      K. FISCHER, P. COLLINS, S. BJÖRKMAN, V. BLANCHETTE, M. OH, S. FRITSCH, P. SCHROTH, G. SPOTTS and B. EWENSTEIN

      Article first published online: 7 FEB 2011 | DOI: 10.1111/j.1365-2516.2010.02450.x

    6. An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies (pages 439–445)

      E. P. MAUSER-BUNSCHOTEN, I. KLEINE BUDDE, S. LOPACIUK, M. M. W. KOOPMAN, F. J. M. Van Der MEER, I. R. O. NOVÀKOVÀ, P. YPMA, P. W. G. Van Der LINDEN, J. WINDYGA and P. F. W. STRENGERS

      Article first published online: 1 MAR 2011 | DOI: 10.1111/j.1365-2516.2010.02453.x

    7. A study of reported factor IX use around the world (pages 446–455)

      J. S. STONEBRAKER, P. H. B. BOLTON-MAGGS, M. BROOKER, A. FARRUGIA and A. SRIVASTAVA

      Article first published online: 7 FEB 2011 | DOI: 10.1111/j.1365-2516.2010.02461.x

    8. Paediatrics

      Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A (pages 456–462)

      A. DMOSZYNSKA, K. KULICZKOWSKI, A. HELLMANN, J. TRELINSKI, J. KLOCZKO, T. BAGLIN, C. HAY, D. O’SHAUGHNESSY, K. ZAWILSKA, M. MAKRIS, R. SHAIKH-ZAIDI, E. GASCOIGNE and C. DASH

      Article first published online: 4 MAR 2011 | DOI: 10.1111/j.1365-2516.2010.02446.x

    9. The clinical efficacy and safety of the FVIII/VWF concentrate, BIOSTATE®, in children with von Willebrand disorder: a multi-centre retrospective review (pages 463–469)

      R. HOWMAN, C. BARNES, J. CURTIN, J. PRICE, J. ROBERTSON, S. RUSSELL, M. SELDON, R. SUPPIAH, L. TEAGUE and G. BARRESE

      Article first published online: 1 DEC 2010 | DOI: 10.1111/j.1365-2516.2010.02445.x

    10. Inhibitors and allergic reactions

    11. Immune tolerance induction in 31 children with haemophilia A: is ITI less successful in African Americans? (pages 483–489)

      M. U. CALLAGHAN, M. RAJPURKAR, M. CHITLUR, I. WARRIER and J. LUSHER

      Article first published online: 1 DEC 2010 | DOI: 10.1111/j.1365-2516.2010.02429.x

    12. Persistent factor VIII inhibitors and orthopaedic complications in children with severe haemophilia A (pages 490–493)

      I. Y. ABDEL-MESSIH, D. M. MOHAMED HABASHY, S. G. MOFTAH and M. EL-ALFY

      Article first published online: 4 MAR 2011 | DOI: 10.1111/j.1365-2516.2010.02447.x

    13. Musculoskeletal

      Range of motion measurements: reference values and a database for comparison studies (pages 500–507)

      J. M. SOUCIE, C. WANG, A. FORSYTH, S. FUNK, M. DENNY, K. E. ROACH, D. BOONE and THE HEMOPHILIA TREATMENT CENTER NETWORK

      Article first published online: 11 NOV 2010 | DOI: 10.1111/j.1365-2516.2010.02399.x

    14. A consensus statement on clinical trials of bypassing agent prophylaxis in inhibitor patients (pages 516–521)

      J. TEITEL, E. BERNTORP, G. DOLAN, K. FISCHER, A. GRINGERI, C. KESSLER, T. LAMBERT, C. LEISSINGER, L. NEMES and M. SHIMA

      Article first published online: 3 MAR 2011 | DOI: 10.1111/j.1365-2516.2010.02440.x

    15. von Willebrand disease

    16. Oral health

      Oral health in adult patients with congenital coagulation disorders – a case control study (pages 527–531)

      D. ZIEBOLZ, C. STÜHMER, E. HORNECKER, A. ZAPF, R. F. MAUSBERG and J. F. CHENOT

      Article first published online: 4 MAR 2011 | DOI: 10.1111/j.1365-2516.2010.02443.x

    17. Laboratory report

      Standardization of thromboelastography: a report from the TEG-ROTEM working group (pages 532–537)

      M. CHITLUR, B. SORENSEN, G. E. RIVARD, G. YOUNG, J. INGERSLEV, M. OTHMAN, D. NUGENT, G. KENET, M. ESCOBAR and J. LUSHER

      Article first published online: 15 FEB 2011 | DOI: 10.1111/j.1365-2516.2010.02451.x

  3. Letters to the Editors

    1. Top of page
    2. Review Articles
    3. Original Articles
    4. Letters to the Editors
    5. Abstracts
    1. Focusing on haemophilia B: prophylaxis in Spanish patients (pages 542–543)

      J. A. AZNAR, J. F. LUCIA, L. ABAD-FRANCH, R. RUBIO, V. JIMENEZ-YUSTE, R. PEREZ, J. BATLLE, I. BALDA, J. MUÑOZ-ROBLES, R. PARRA and ON BEHALF OF THE SPANISH HAEMOPHILIA EPIDEMIOLOGICAL STUDY WORKING GROUP

      Article first published online: 11 NOV 2010 | DOI: 10.1111/j.1365-2516.2010.02412.x

    2. Identification of novel and recurrent mutations in Tunisian haemophilia B patients (pages 544–545)

      H. ELMAHMOUDI, H. KHODJET-EL-KHIL, M. BEN-AMOR, A. JLIZI, K. ZAHRA, B. MEDDEB, A. BEN-AMMAR- EL-GAAIED and E. GOUIDER

      Article first published online: 1 DEC 2010 | DOI: 10.1111/j.1365-2516.2010.02442.x

    3. Massive retroperitoneal haemorrhage in a neonate with severe haemophilia A (pages 547–548)

      R. GRIZELJ, J. VUKOVIĆ, E. BILIĆ and R. ŠTERN-PADOVAN

      Article first published online: 11 NOV 2010 | DOI: 10.1111/j.1365-2516.2010.02409.x

    4. Dengue virus infection in haemophilic patients: aggravation of bleeding risk (pages 553–556)

      A. CHUANSUMRIT, K. TANGNARARATCHAKIT, N. SIRACHAINAN, A. KHOSITSETH, T. KUPTANON, S. WANITKUN, W. WITHURAWANIT and D. SONGDEJ

      Article first published online: 11 NOV 2010 | DOI: 10.1111/j.1365-2516.2010.02413.x

  4. Abstracts

    1. Top of page
    2. Review Articles
    3. Original Articles
    4. Letters to the Editors
    5. Abstracts

SEARCH

SEARCH BY CITATION